Novartis AG
ANTIBODY DRUG CONJUGATES
Last updated:
Abstract:
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
9 Dec 2019
Issue date:
30 Apr 2020